Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
11/17/20214:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/17/20214:13PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
11/17/20214:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/17/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/17/20214:01PMBusiness WireImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of DirectorsNASDAQ:IMGNImmunoGen Inc
11/16/20214:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
11/16/20216:30AMBusiness WireImmunoGen Appoints Kristen Harrington-Smith as Senior Vice President and Chief Commercial OfficerNASDAQ:IMGNImmunoGen Inc
11/04/20219:00AMBusiness WireImmunoGen to Present Initial Data Combining IMGN632 with Vidaza® and Venclexta® in Relapsed/Refractory Acute Myeloid Leukemia at ASHNASDAQ:IMGNImmunoGen Inc
11/01/20218:03PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
10/29/20216:45AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
10/29/20216:30AMBusiness WireImmunoGen Reports Recent Progress and Third Quarter 2021 Financial ResultsNASDAQ:IMGNImmunoGen Inc
10/14/20214:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Third Quarter 2021 Operating ResultsNASDAQ:IMGNImmunoGen Inc
10/01/20214:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
09/23/20214:34PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
09/23/20214:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
09/22/20214:01PMBusiness WireImmunoGen Appoints Helen M. Thackray, MD to its Board of DirectorsNASDAQ:IMGNImmunoGen Inc
09/03/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
08/12/202110:12AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IMGNImmunoGen Inc
08/09/20214:11PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
08/09/20214:11PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
08/02/20214:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
07/30/20215:13PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
07/30/20216:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
07/30/20216:30AMBusiness WireImmunoGen Reports Recent Progress and Second Quarter 2021 Financial ResultsNASDAQ:IMGNImmunoGen Inc
07/15/20214:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Second Quarter 2021 Operating ResultsNASDAQ:IMGNImmunoGen Inc
07/02/20214:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/20214:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/20214:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/20214:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/20214:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN